Atlab Pharma
Nantes · Founded 2008
About Atlab Pharma
ATLAB Pharma develops antibody-targeted radiotherapy for cancer treatment. Radioimmunotherapy is a tumor-specific delivery system using monoclonal antibodies conjugated to radioisotopes (radio-antibodies) to target radiation to cancer cells wherever they have disseminated in the body, thus expanding the well-proven efficacy of radiotherapy from localized tumors to metastatic cancers.
Company Facts
- Founded: 2008
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: atlab-pharma.com
Social Profiles
Canonical: https://fsome.com/organization/atlab-pharma-8435997 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.